Based on forecasted data, the sales values (in billion Euros) are as follows:
- 2024: 1.7
- 2025: 1.72
- 2026: 1.75
- 2027: 1.77
- 2028: 1.79
The year-on-year percentage variations are:
- 2025: 1.18%
- 2026: 1.74%
- 2027: 1.14%
- 2028: 1.13%
The average yearly variation over the last 5 years is 1.05%.
The market for respiratory system medicines in Spain is expected to demonstrate steady growth through 2028, driven by advances in medical research, aging population demographics, and increasing awareness of respiratory health. Stakeholders should monitor regulatory changes and the introduction of innovative treatments.
